IA
MED icon

IFG Advisory’s Medifast MED Stock Holding History

IFG Advisory’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149 Buy
+14
New +$161 ﹤0.01% 2297

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IFG Advisory's MED Position: Q2 2026 in Review

IFG Advisory opened a new position in Medifast (MED) in Q2 2026: 14 shares worth $149. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings.

113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • IFG Advisory held 14 shares of Medifast worth $149 as of Q2 2026.
  • Medifast was a new IFG Advisory position in Q2 2026.
  • Medifast made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #2297 holding.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.